字号·· | 护眼
美国有线电视新闻网

特朗普突然撤回FDA局长人选,官员措手不及,关键参议员大为光火Sudden withdrawal of Trump’s FDA pick blindsided officials and left key senator fuming

点「原文对照」整页切到原文,或双击某段只看那段的原文。

乔纳森·恩斯特/联合采访团/路透社Jonathan Ernst/Pool/Reuters

资深卫生官员对白宫决定放弃提名海迪·奥弗顿博士出任食品药品监督管理局(FDA)局长一职感到措手不及,就在几小时前,他们还认为奥弗顿终于获得了足够的参议院支持以推进提名程序,六位知情人士向CNN透露了此事。

Senior health officials were blindsided by the White House decision to abandon Dr. Heidi Overton, its nominee to run the Food and Drug Administration, just hours after they believed she’d finally secured enough Senate support to advance, a half-dozen people familiar with the matter told CNN.

周二深夜做出的这一决定来得如此突然,以至于奥弗顿的团队是从Axios的一篇报道中得知她的命运的,其中一些人最初坚称这肯定是个错误,两位知情人士表示。

The decision late Tuesday night was so sudden that Overton’s team found out about her fate from an Axios report that some of them initially insisted had to be a mistake, two of those people said.

从那时起,奥弗顿的盟友们确信,白宫利用参议院的不确定性作为借口,扼杀了一位候选人。自特朗普最初赞誉她为“超级巨星”提名人以来的几个月里,卫生与公众服务部长小罗伯特·肯尼迪和新任白宫幕僚长斯蒂芬·米勒已对她心生芥蒂。

Since then, Overton’s allies have grown convinced that the White House used the Senate uncertainties as justification to kill a candidate that Health and Human Services Secretary Robert F. Kennedy Jr. and new White House chief of staff Stephen Miller had soured on in the months since Trump first hailed her as a “ROCKSTAR” nominee.

“我认为她绝对有足够的票数,”一位知情人士说。“没有任何迹象表明她有问题。” 这一令人震惊的撤回提名举动,是在她的团队与几位持观望态度的共和党参议员进行了数天谈判之后发生的。知情人士透露,周二下午,她的团队刚刚向参议员乔什·霍利做出了一系列让步,以争取官方视为关键的最后一票。

“I think she absolutely had the votes,” one of those people familiar with the matter said. “There wasn’t any indication that she had an issue.”The surprise move to pull Overton’s nomination followed days of negotiations between her team and a handful of holdout GOP senators. Her team had just made a series of concessions Tuesday afternoon to Sen. Josh Hawley to win what officials saw as the crucial final vote, the sources said.

但在达成这项协议几小时后,白宫却放弃了奥弗顿的候选人资格——让资深卫生与公众服务部官员措手不及,并激怒了参议院卫生委员会共和党主席比尔·卡西迪。白宫和卫生与公众服务部的发言人均未就此事回应置评请求。

But hours after striking that deal, the White House dropped Overton’s candidacy — catching senior HHS officials off-guard and angering Sen. Bill Cassidy, the Republican chair of the Senate’s health committee. Spokespeople for the White House and the Health and Human Services Department did not respond to requests for comment on the episode.

事后,特朗普政府官员似乎没有快速提名替代者的计划——这增加了共和党在明年1月将参议院控制权移交给民主党之前,无法确认一位正式FDA局长的可能性。

In the aftermath, Trump officials did not appear to have a plan to quickly nominate a replacement — raising the prospect that Republicans will fail to confirm a permanent FDA commissioner before handing Senate control over to Democrats in January.

这个数十亿美元预算的机构负责美国人的食品和处方药安全,自5月以来一直没有常任局长。三位知情人士表示,现任代理局长凯尔·迪亚曼塔斯(Kyle Diamantas)普遍预计将在年底前离开FDA。

The multibillion-dollar agency, which is responsible for the safety of Americans’ food and prescription medicines, has not had a permanent commissioner since May. Current acting chief Kyle Diamantas has been widely expected to leave the FDA by the end of the year, three of the people familiar said.

据两位消息人士透露,卡西迪对这一突然撤回提名感到愤怒,并在X平台发帖表示,奥弗顿本应有足够票数在其委员会推进提名,从而似乎排除了今年再考虑另一位提名人的可能性。

Cassidy was livid over the abrupt withdrawal, according to two of the sources, and appeared to rule out considering another nominee this year in an X post that insisted Overton would have had the votes to advance out of his committee.

他写道:“遗憾的是,鉴于剩余时间有限,确认常任FDA局长将落在参议院民主党人身上。”卡西迪曾支持肯尼迪的确认,但此后已成为其主要对手之一,他在今年早些时候的初选中失利,将在任期结束时离开国会。

“Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats,” he wrote. Cassidy, who backed Kennedy’s confirmation but has since emerged as one of his chief antagonists, lost his primary election earlier this year and is leaving Congress at the end of the term.

周三,他还表示不会推进吉姆·奥尼尔(Jim O’Neill)的提名,后者是政府挑选的国家科学基金会局长人选,因为他觉得该候选人“在为科学辩护、反对不负责任的决定和言论方面做得不够”,指的是奥尼尔在HHS担任副职期间面对肯尼迪的相关表现。

On Wednesday, he also said he would not advance the nomination for Jim O’Neill, the administration’s pick to lead the National Science Foundation, because he felt the candidate “did not do enough to stand up for science and against irresponsible decisions and statements” from Kennedy when O’Neill served as a deputy at HHS.

政府官员普遍预期,明年民主党不会支持任何与肯尼迪立场一致的提名人,他们长期以来一直批评肯尼迪的反疫苗政策及对该部门的整体管理。

There is little expectation among administration officials that Democrats next year will support any nominee aligned with Kennedy, who they have long criticized over his anti-vaccine policies and broader stewardship of the department.

终止奥弗顿的提名引发了新一轮相互指责,恐将加深共和党内部在政府医疗卫生议程上的现有分歧。这也是米勒计划授权肯尼迪更自由地追求其雄心的最新迹象,此前白宫曾花费数月时间试图有效边缘化他最具争议且政治上最不受欢迎的政策。

Ending Overton’s nomination has stoked fresh rounds of finger-pointing that threaten to deepen existing divides within the GOP over the administration’s healthcare agenda. And it served as the latest sign that Miller plans to empower Kennedy to more freely pursue his ambitions, after months of White House efforts to effectively sideline his most divisive and politically unpopular policies.

本月早些时候,特朗普提拔米勒出任白宫幕僚长,米勒被广泛认为比前任苏西·怀尔斯更支持肯尼迪的“让美国再次健康”纲领。据知情人士透露,这位卫生与公众服务部部长此前在担任白宫高级国内政策官员期间曾与奥弗顿发生冲突,当时她是卫生与公众服务部领导层与西翼高级助手之间的主要联络渠道。

Miller, who Trump promoted to chief of staff earlier this month, is widely seen as more supportive of Kennedy’s “Make America Healthy Again” platform than former chief Susie Wiles. The HHS secretary, meanwhile, had previously clashed with Overton during her time as a senior White House domestic policy official, where she served as the main conduit between HHS leaders and top West Wing aides, the people familiar with the matter said.

过去几个月里,肯尼迪及其盟友逐渐视奥弗顿为其议程的阻碍,部分人指责她拖延甚至彻底搁置了一系列关键政策。奥弗顿的支持者反驳称,她在白宫层面一直是“让美国再次健康”运动的关键倡导者——而放缓的原因在于特朗普政策优先事项在中期选举前的更广泛转变。

Over the last several months, Kennedy and his allies came to see Overton as an impediment to his agenda, with some blaming her for slowing or outright stalling a series of key policies. Overton’s defenders countered that she had been a key MAHA advocate at the White House level — and that the slowdown was driven by a broader shift in Trump’s policy priorities ahead of the midterm elections.

知情人士透露,特朗普于8月提名奥弗顿出任食品药品监督管理局局长,部分基于怀尔斯的背书。

Trump nominated Overton in August to run the FDA based in part on the endorsement of Wiles, the people familiar with the matter said.

但自特朗普以米勒取代怀尔斯后,白宫内部关于奥弗顿提名命运的讨论迅速升温,知情人士称。特朗普官员上周至周末期间争论,是否要为她的确认之战投入政治资本——或是彻底放弃她的提名。

But after Trump replaced Wiles with Miller, White House discussions about the fate of Overton’s candidacy quickly intensified, the people familiar said. Trump officials debated last week and into the weekend over whether to devote political capital to her confirmation bid — or abandon her candidacy altogether.

一系列公开攻击也损害了奥弗顿的地位,发起攻击的是前卫生与公众服务部高级官员卡利·米恩斯,他是肯尼迪的亲密盟友,指责奥弗顿和怀尔斯将企业利益置于“让美国再次健康”议程之上,并归咎于她导致该运动的一系列政策挫折。

Overton’s standing was also hurt by a series of public attacks levied by former senior HHS official Calley Means, a close Kennedy ally who accused her and Wiles of prioritizing corporate interests over the MAHA agenda and blamed her for a range of the movement’s policy setbacks.

这些指控在白宫内部获得关注,米勒此前已采取一些早期举措,被视为对怀尔斯团队的斥责——包括禁止在未获事先批准的情况下,在白宫场地内与游说人士会面。这些指控还激发了更广泛的“让美国再次健康”运动内部对奥弗顿的反对,推动活动人士公开和私下敦促官员撤回她的提名。

The allegations gained traction within the White House, where Miller had already taken some early steps viewed as a rebuke of Wiles’ operation — including banning meetings with lobbyists on the White House grounds without prior approval. The allegations also energized opposition to Overton across the broader MAHA movement, spurring activists to urge officials in public and private to drop her nomination.

“她是苏西的人,”一位知情人士说。“他们肯定是在盼着她失败。”与此同时,奥弗顿和参与她提名工作的高级卫生官员加紧了争取足够参议院票数的行动。两位知情人士说,奥弗顿上周与卡西迪私下会面,她的团队认为这次会晤锁定了他的支持。这位参议员随后在X平台发帖确认,他原本计划投她的赞成票。

“She was Susie’s person,” a person familiar with the matter said. “They were definitely rooting for her failure.”Overton and senior health officials working on her nomination had stepped up their campaign to win the sufficient Senate votes in the meantime. Overton met privately with Cassidy last week, in a sit down that her team believed locked in his support, two of the people familiar said. The senator, in his X post, later confirmed he’d planned to vote for her.

两位知情人士说,卫生官员还派遣医疗补助和医疗保障官员梅赫梅特·奥兹博士代表奥弗顿打电话,以缓解包括共和党温和派穆尔科斯基和柯林斯在内的参议员的残留顾虑。穆尔科斯基和柯林斯的发言人未回应置评请求。

Health officials had also worked to assuage the lingering concerns of senators, including GOP moderates Lisa Murkowski and Susan Collins, by dispatching Medicaid and Medicare official Dr. Mehmet Oz to make calls on Overton’s behalf, two of the people said. Spokespeople for Murkowski and Collins did not respond to requests for comment.

奥弗顿团队周二认为,最后的挑战是争取坚决反堕胎的霍利的支持。官员们最终在当天下午作出了一系列承诺,涉及美国食品药品监督管理局(FDA)正在进行的米非司酮研究,米非司酮是美国使用最广泛的堕胎药,承诺内容包括在该机构网站上公布研究预计完成日期。

The final challenge, Overton’s team believed on Tuesday, was winning over the stridently anti-abortion Hawley. Officials ultimately made a handful of commitments that afternoon tied to the FDA’s ongoing study of mifepristone, the nation’s most-used abortion pill, including posting the study’s anticipated completion date on the agency’s website.

霍利周三对记者说:“我认为她的回答完全回应了我提出的一切要求,”并称赞她作出了“任何提名人在生命议题上作出的最有力承诺”。周二,卫生官员已对奥弗顿能通过委员会审查充满信心,迹象显示他们已在谋划让她与另一位反堕胎参议员、蒙大拿州的史蒂夫·戴恩斯会面,她在参议院全体表决前需要他的支持。

“I thought her responses were completely responsive to everything I asked for,” Hawley told reporters on Wednesday, praising her for the “strongest commitments any nominee has made on life.”In a sign of heath officials’ confidence on Tuesday that Overton would advance through committee, they were already plotting to have her meet with another anti-abortion senator, Steve Daines of Montana, whose support she would need ahead of her final confirmation vote in the full Senate.

但白宫随即撤回了她的提名,突然终结了奥弗顿为期三个月的候选人资格,使她未能迎来任何一次有记录的表决。

But the White House yanked her nomination shortly afterward, abruptly ending Overton’s three-month candidacy before she could reach a single recorded vote.

阅读媒体原文 ↗